NIH

Tweet Follow @ResearchAmerica Six science-savvy teams comprised of researchers from around the globe are currently in the running for a grand prize of $230,000 to develop new big data methods for advancing biomedical research. The two-phased Open Science Prize contest was made possible through a collaboration between the National Institutes of Health (NIH) , the Wellcome Trust and the Howard Hughes Medical Institute . During the first phase, the teams received prize money to help create tools or services that could be used to tackle important issues in biomedicine and improve health. They designed prototypes to address subjects such as neuroimaging, rare diseases, mental and neurological...
Dear Research Advocate, As we prepare to celebrate Thanksgiving, it is fitting to thank our public health workforce for their tireless efforts on our behalf every day of the year. Monday marked the official Public Health Thank You Day (PHTYD), but it is ongoing. This year’s effort has been extraordinary, with more than 50 organizations partnering with us to get the word out. For the first time since we launched PHTYD in 2005, Congress officially joined the effort. As I mentioned last week, the co-chairs of the House Public Health Caucus introduced a resolution supporting PHTYD. Online, more than 1,000 organizations and individuals participated, including federal officials from HHS and DOD,...
A new report prepared by leading scientists, thought leaders and policy experts, A Vision and Pathway for NIH , includes recommendations for the new Administration to further advance the nation’s leading biomedical research and health agency-- the National Institutes of Health (NIH). The goal is to better align agency organization and policies with present and future strategies for achieving the highest impact in research and training, and improving health outcomes. The report, written by an ad hoc working group, led by Research!America board member Keith Yamamoto, Ph.D., Vice Chancellor for Science Policy and Strategy; Director, UCSF Precision Medicine; Vice Dean for Research, School of...
Dear Research Advocate: A very close election has entered the history books, in the process laying bare the profound divisions that will challenge all our elected representatives as they seek to unify and heal the nation. We have been deluged with questions about the impact of a Trump Administration on science. A useful primer is his answers to the ScienceDebate.org questionnaire that we and several other groups worked together to create. For example, President-elect Trump says this: “...the federal government should encourage innovation in the areas of space exploration and investment in research and development across the broad landscape of academia.” He also says this: “Though there are...
What, in y our view, are the major challenges facing our nation’s research enterprise? Biomedical research is the driving force behind decades of advances that have improved the health of people in every corner of America—including the lives of those affected by breast cancer. With a robust and sustained investment in biomedical research, the possibilities would be endless. The National Institutes of Health (NIH) and its National Cancer Institute (NCI) have played a role in every major cancer prevention, detection and treatment advance in breast cancer for decades. Within the NIH, the NCI is the principal agency for cancer research and training. The NCI has funded numerous major breast...
U.S. investments in medical and health research and development (R&D) grew by 13.3% over a three year period (2013 – 2015), according to Research!America’s new investment report . However, medical and health R&D represents a small fraction of total spending on health. Currently, the U.S. spends less than 5 cents of every health dollar on R&D to prevent, treat, and cure disease. More than half of Americans (56%) say that is not enough, a recent public opinion survey shows. Industry, including pharmaceutical, medical technolo­gy, biotechnology and health IT companies, invests more in R&D than other sectors. In 2015, industry invested 64.7% of total spending, followed by the...
Founded in 1977, the American Pain Society (APS) is a multidisciplinary organization of basic and clinical scientists, practicing clinicians, policy analysts and others who conduct pain research, treat pain and advocate for individuals with pain. The mission of APS is to advance pain-related research, education, treatment and professional practice. In 2010, after a decade of APS advocacy efforts to address pain as a national issue, the National Institutes of Health (NIH) contracted with the Institute of Medicine (IOM) to undertake a study and make recommendations “to increase the recognition of pain as a significant public health problem in the United States.” According to their landmark...
The American Association for Cancer Research (AACR) has released the annual Cancer Progress Report , highlighting advances in cancer research, as well as advocating for sustained and robust funding for federal health agencies. AACR also hosted a congressional briefing on the progress report on Wednesday, September 21 to bring to Congress’ attention the importance of funding for research and emphasized patient involvement in moving research forward. Patient participation in clinical trials is important not only to test the efficacy of cancer drugs, but also to further the precision medicine initiative that aims to individualize cancer treatment based on each patient’s genetic code and...
Across the United States, hundreds of thousands of researchers are working to better understand a wide range of diseases and conditions, from cancer to heart disease, to rare disorders to Alzheimer disease, and countless others, in order to improve the health and well-being of people in every corner of America and the world. The lifeblood for the majority of these researchers is federal funding received through the National Institutes of Health (NIH). Through more than 57,000 research and training grants, NIH directly supports approximately 300,000 researchers at more than 2,500 universities and organizations located in all 50 states. This funding, in turn, supports local economies and...
Watch the videos from each panel, read the transcript , view the photo gallery and read the WebMD live recap . “The biomedical research enterprise underpins the health of the nation and much of the world, and is in dire need of substantial infusion to meet the great medical needs of our time,” said William N. Hait, M.D., Ph.D. , global head, Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, the keynote speaker at the 2016 National Health Research Forum, added that we’re losing time in addressing threats like the Zika virus, Ebola and cancer while waiting for funding to improve for biomedical research. The program, held Thursday,...

Pages

Sidebar Quote

America’s economic destiny lies in innovation, technology, science and research.
The Honorable John E. Porter